Hester Bios

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
2,505.00
85.95 (3.55%)
BSENSE

Aug 10

BSE+NSE Vol: 12.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
NGL Fine Chem
Venus Remedies
Sakar Healthcare
Windlas Biotech
Ind-Swift Labs.
Hester Bios
Solara Active
Indoco Remedies
Panacea Biotec
Sai Parenteral's
Why is Hester Biosciences Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.67 times
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.67 times
  • The company has been able to generate a Return on Capital Employed (avg) of 8.56% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Operating profit has grown by an annual rate 4.14% of over the last 5 years
3
With ROCE of 12.4, it has a Very Expensive valuation with a 3.3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 5.75%, its profits have risen by 95.3% ; the PEG ratio of the company is 0.3
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hester Bios for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Hester Bios
28.29%
0.16
36.97%
Sensex
-1.65%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.78%
EBIT Growth (5y)
1.42%
EBIT to Interest (avg)
4.51
Debt to EBITDA (avg)
3.94
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
0.55
Tax Ratio
12.97%
Dividend Payout Ratio
16.82%
Pledged Shares
0
Institutional Holding
0.32%
ROCE (avg)
8.83%
ROE (avg)
10.95%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
40
Industry P/E
37
Price to Book Value
5.92
EV to EBIT
35.75
EV to EBITDA
26.78
EV to Capital Employed
4.23
EV to Sales
7.12
PEG Ratio
0.98
Dividend Yield
0.44%
ROCE (Latest)
12.36%
ROE (Latest)
14.91%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
PAT(Latest six months)

At Rs 29.83 cr has Grown at 68.22%

ROCE(HY)

Highest at 15.11%

DEBT-EQUITY RATIO(HY)

Lowest at 0.54 times

EPS(Q)

Highest at Rs 113.96

-9What is not working for the Company
INTEREST(Latest six months)

At Rs 8.18 cr has Grown at 102.98%

PBT LESS OI(Q)

At Rs 14.69 cr has Fallen at -17.80%

DPR(Y)

Lowest at 16.82%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 6.54 cr

NET SALES(Q)

At Rs 77.24 cr has Grown at -8.17%

Loading Valuation Snapshot...
Here's what is working for Hester Bios
Profit After Tax (PAT) - Latest six months
At Rs 29.83 cr has Grown at 68.22%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.54 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Earnings per Share (EPS) - Quarterly
Highest at Rs 113.96
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Hester Bios
Interest - Latest six months
At Rs 8.18 cr has Grown at 102.98%
over previous Half yearly period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 14.69 cr has Fallen at -17.80%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
At Rs 77.24 cr has Grown at -8.17%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 6.54 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Dividend Payout Ratio (DPR) - Annually
Lowest at 16.82%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)